Abiopharma

(90% Positive) Axsome Therapeutics, Inc. (AXSM) Announces Enrollment Update for held Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(80% Positive) IMMUNIC, INC. (IMUX) Announces Enrollment Update for Million Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

(75% Positive) CENTESSA PHARMACEUTICALS PLC (CNTA) Announces Clinical Development Update

(99% Neutral) Galapagos NV (GLPG) Files Form 6-K

(99% Neutral) Autolus Therapeutics plc (AUTL) Announces 2022 Annual General Meeting

(99% Neutral) IGM Biosciences, Inc. (IGMS) Announces New Board Appointment

(99% Neutral) PRAXIS PRECISION MEDICINES, INC. (PRAX) Announces Regulatory Update

(80% Positive) ChemoCentryx, Inc. (CCXI) Provides Update on roles for science

(10% Negative) Summit Therapeutics Inc. (SMMT) Announces Delay in difference Trials for multiple business unit CFO roles Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process

(99% Neutral) CureVac (CVAC) Files Form 6-K